Shi-Ao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shi-Ao Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Xian-Bo Wu
Department of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, 510515, China
3 shared publications Bi-Fei Cao
Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China
2 shared publicationsHao-Wen Chen
Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China
2 shared publicationsKuan Liu
Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China
2 shared publicationsQi Zhong
Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China
2 shared publicationsYan-Fei Wei
Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China
2 shared publications
Latest Publications
- 1 April 2026
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (6) , 1299-1309
Association between metabolic signatures of predicted VAT mass and risk of MASLD and other chronic liver diseases
Background and aims Visceral adipose tissue (VAT) plays a key role in metabolic dysfunction, and it is increasingly recognised as a contributor to metabolic dysfunction-associated steatotic liver disease (MASLD) and other chronic liver conditions. However, the systemic metabolic pathways linking VAT to liver disease remain unclear. This study aimed to identify metabolic signatures associated with VAT and examine their potential role as mediators in the relationship between VAT accumulation and the risks of MASLD, cirrhosis and hepatoma. Methods This prospective study included 269,018 UK Biobank participants without baseline liver disease. Predicted VAT mass was estimated using sex-specific models on the basis of anthropometric and bioimpedance measures. Incident liver outcomes were identified via ICD-coded hospital records. A VAT-related metabolic signature was derived from 251 circulating metabolites by using elastic net regression. Associations with liver disease risks were assessed using Cox models. Mediation analysis estimated the proportion of the VAT–MASLD association explained by the metabolic signature. Results Over a median follow-up of 14.3 years, 2658 MASLD, 671 cirrhosis and 444 hepatoma cases occurred. Each standard deviation increase in VAT was associated with increased risks of MASLD (HR: 1.70; 95% CI: 1.62–1.79), cirrhosis (HR: 1.27; 95% CI: 1.15–1.40) and hepatoma (HR: 1.15; 95% CI: 1.02–1.30). The VAT-related metabolic signature (156 metabolites, primarily lipoprotein subclasses and lipids) was independently associated with MASLD (HR: 1.89; 95% CI: 1.72–2.08) and mediated 40.0% of the VAT–MASLD association. No significant mediation was observed for cirrhosis or hepatoma. Conclusions VAT and its metabolic signature are strongly associated with MASLD risk, partly explaining its pathogenesis through systemic metabolic alterations.
- 1 April 2026
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (6) , 1299-1309
Association between metabolic signatures of predicted VAT mass and risk of MASLD and other chronic liver diseases
Background and aims Visceral adipose tissue (VAT) plays a key role in metabolic dysfunction, and it is increasingly recognised as a contributor to metabolic dysfunction-associated steatotic liver disease (MASLD) and other chronic liver conditions. However, the systemic metabolic pathways linking VAT to liver disease remain unclear. This study aimed to identify metabolic signatures associated with VAT and examine their potential role as mediators in the relationship between VAT accumulation and the risks of MASLD, cirrhosis and hepatoma. Methods This prospective study included 269,018 UK Biobank participants without baseline liver disease. Predicted VAT mass was estimated using sex-specific models on the basis of anthropometric and bioimpedance measures. Incident liver outcomes were identified via ICD-coded hospital records. A VAT-related metabolic signature was derived from 251 circulating metabolites by using elastic net regression. Associations with liver disease risks were assessed using Cox models. Mediation analysis estimated the proportion of the VAT–MASLD association explained by the metabolic signature. Results Over a median follow-up of 14.3 years, 2658 MASLD, 671 cirrhosis and 444 hepatoma cases occurred. Each standard deviation increase in VAT was associated with increased risks of MASLD (HR: 1.70; 95% CI: 1.62–1.79), cirrhosis (HR: 1.27; 95% CI: 1.15–1.40) and hepatoma (HR: 1.15; 95% CI: 1.02–1.30). The VAT-related metabolic signature (156 metabolites, primarily lipoprotein subclasses and lipids) was independently associated with MASLD (HR: 1.89; 95% CI: 1.72–2.08) and mediated 40.0% of the VAT–MASLD association. No significant mediation was observed for cirrhosis or hepatoma. Conclusions VAT and its metabolic signature are strongly associated with MASLD risk, partly explaining its pathogenesis through systemic metabolic alterations.
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1645-1660
Role of Ruminococcus gnavus in the elderly with cognitive impairment: A case-control study and an animal experiment
Background: Cognitive impairment (CI) is a complex condition, and older adults with CI are several times more likely to develop Alzheimer's disease (AD) than their cognitively normal peers. The gut–brain axis plays a crucial role in neurodegeneration, with gut microbiota potentially affecting cognition via autophagy regulation. Objective: This study aims to elucidate the association between Ruminococcus gnavus and CI in older adults, dissect the autophagy-related mechanisms potentially involved in this association and provide new insights and evidence for the role of R. gnavus in AD-related CI. Methods: Fecal 16S rRNA profiles from 30 elders with CI and 30 matched controls were compared, then pseudo-germ-free aged mice were monocolonized with R. gnavus . Cognitive performance (Morris water maze), autophagy markers (quantitative PCR, western blot analysis, histology and ELISA) and untargeted metabolomics were evaluated to identify autophagy-related pathways. Results: R. gnavus was enriched in patients with CI and inversely correlated with Mini-Mental State Examination scores. In aged pseudo-germ-free mice monocolonized with R. gnavus , learning and memory declined and autophagy was suppressed: the mRNA levels of Atg2a , Atg5 , Atg7 , Atg9a , Atg14 , Atg16 , Beclin-1 , Lc3b and Ulk1 decreased, whereas P62 increased. Consistent protein changes, decreased LC3B and Beclin-1 levels with elevated P62 and immunohistochemistry indicated reduced LC3B-positive plaques in the CA1, CA3 and cortex. Metabolomics revealed disrupted glycerophospholipid metabolism and enriched autophagy-related pathways. Conclusions: The enrichment of R. gnavus is associated with CI, with autophagy potentially mediating its effects on cognition via the gut–brain axis. Causality remains to be established through longitudinal studies.
- 1 September 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1645-1660
Role of Ruminococcus gnavus in the elderly with cognitive impairment: A case-control study and an animal experiment
Background: Cognitive impairment (CI) is a complex condition, and older adults with CI are several times more likely to develop Alzheimer's disease (AD) than their cognitively normal peers. The gut–brain axis plays a crucial role in neurodegeneration, with gut microbiota potentially affecting cognition via autophagy regulation. Objective: This study aims to elucidate the association between Ruminococcus gnavus and CI in older adults, dissect the autophagy-related mechanisms potentially involved in this association and provide new insights and evidence for the role of R. gnavus in AD-related CI. Methods: Fecal 16S rRNA profiles from 30 elders with CI and 30 matched controls were compared, then pseudo-germ-free aged mice were monocolonized with R. gnavus . Cognitive performance (Morris water maze), autophagy markers (quantitative PCR, western blot analysis, histology and ELISA) and untargeted metabolomics were evaluated to identify autophagy-related pathways. Results: R. gnavus was enriched in patients with CI and inversely correlated with Mini-Mental State Examination scores. In aged pseudo-germ-free mice monocolonized with R. gnavus , learning and memory declined and autophagy was suppressed: the mRNA levels of Atg2a , Atg5 , Atg7 , Atg9a , Atg14 , Atg16 , Beclin-1 , Lc3b and Ulk1 decreased, whereas P62 increased. Consistent protein changes, decreased LC3B and Beclin-1 levels with elevated P62 and immunohistochemistry indicated reduced LC3B-positive plaques in the CA1, CA3 and cortex. Metabolomics revealed disrupted glycerophospholipid metabolism and enriched autophagy-related pathways. Conclusions: The enrichment of R. gnavus is associated with CI, with autophagy potentially mediating its effects on cognition via the gut–brain axis. Causality remains to be established through longitudinal studies.
- Top Cited Papers
- 31 August 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (3) , 427-437
Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases
- 31 August 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (3) , 427-437
Top Cited PapersFrailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases